Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab

Letter to the Editor

Saved in:

Bibliographic Details
Published in	Annals of hematology Vol. 94; no. 12; pp. 2061 - 2062
Main Authors	坂田（柳元）麻実子, 佐藤泰樹, 横山泰久, 栗田尚樹, 小原直, 長谷川雄一, 野口雅之, 千葉滋, Muroi Kei, Sakata-Yanagimoto Mamiko, Sato Taiki, Yokoyama Yasuhisa, Maie Koichiro, Kurita Naoki, Obara Naoshi, Hasegawa Yuichi, Noguchi Masayuki, Chiba Shigeru
Format	Journal Article
Language	English
Published	Berlin/Heidelberg Springer 01.12.2015 Springer Berlin Heidelberg Springer Nature B.V
Subjects	Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Bendamustine Hydrochloride - administration & dosage Bendamustine Hydrochloride - adverse effects Epstein-Barr virus Epstein-Barr Virus Infections - chemically induced Female Hematology Herpesvirus 4, Human Humans Letter to the Editor Lymphoma, Follicular - drug therapy Lymphoma, Follicular - virology Medicine Medicine & Public Health Middle Aged Oncology Rituximab - administration & dosage Rituximab - adverse effects Lymphoproliferative Disorder Follicular Lymphoma Bendamustine Progressive Multifocal Leukoencephalopathy Axillary Lymph Node
Online Access	Get full text
ISSN	0939-5555 1432-0584
DOI	10.1007/s00277-015-2463-3

More Information
Summary:	Letter to the Editor
Bibliography:	SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14
ISSN:	0939-5555 1432-0584
DOI:	10.1007/s00277-015-2463-3